Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by skyplton May 23, 2019 1:20pm
148 Views
Post# 29768480

VFF to APHA

VFF to APHASold my remaining shares of VFF today at 18.60 and bought APHA at 8.80. Of course, I then watched VFF continue above 19 for a bit and APHA hit 8.68. It is impossible to time these things. I am most appreciative of VFF giving me some spending money; but I do believe APHA has far more potential. Today is ugly. But it is ugly across the board. I even see VFF is now below 18. Sentiment on APHA has gone from hostile to depression. I keep coming back for the same reasons; 255K kgs per year and the extraction centre. However, until we start seeing production numbers and extraction output I am afraid we are at the mercy of general market sentiment. APHA is considered a writeoff by most. When I see comments like "MedMen is the new Aphria" and the like I know we have a big credibility hill to climb. Aphria has become the benchmark for perceived mismanagement and failure to execute. Simple fact is, all of those things that were there when this stock was at 20 are still here. Days like today are growing wearisome. I am glad to no longer be one margin and thus can wait this out. It still stinks though.
Bullboard Posts